Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Dr. Albina Tummolo | Medicine and Health Sciences | Best Researcher Award

Albina Tummolo at Children Hospital Giovanni XXIII, Italy.

Dr. Albina Tummolo is an accomplished pediatrician specializing in metabolic and genetic disorders. With over two decades of clinical and academic experience, she has built a significant profile in managing and researching rare pediatric diseases. Based at the Policlinico of Bari, she combines patient care with academic research, national coordination roles, and continuous engagement with international advisory boards. Dr. Tummolo is also an active educator, teaching at several Italian universities and training healthcare professionals in hereditary metabolic diseases. Her work has shaped protocols and policies for improved pediatric metabolic care in Italy.

Publication Profile

Orcid

Education

Dr. Albina Tummolo earned her Degree in Medicine and Surgery from the University of Foggia in 2002 and completed her Specialization in Pediatrics (General and Specialist) at the University of Bari in 2007. She holds multiple postgraduate certifications in specialized pediatrics, infectivity, rheumatology, and rare diseases from the University of Bari and the University of Florence. She furthered her academic credentials with an MSc in Clinical Pediatrics from University College London in 2008 and a PhD in Pediatric Sciences from the University of Bari in 2011. In 2023, she completed an MSc in Epidemiology and Biostatistics at Università Cattolica di Roma.

Experience

Dr. Tummolo currently serves as a Senior Pediatrician at the Ospedale Pediatrico “Giovanni XXIII” in Bari, within the Unit of Metabolic and Genetic Diseases, a role she has held since 2015. She has also worked as a senior pediatrician at the Azienda Ospedaliera di Padova and Presidio Ospedaliero “Perrino” dell’ASL di Brindisi. She is a registered physician with the Order of Physicians and Surgeons of Bari (License No. 5742, since September 18, 2003).

Dr. Tummolo has extensive experience leading and participating in clinical trials and observational studies focused on inborn errors of metabolism, lysosomal storage disorders, and rare genetic conditions, often acting as Principal Investigator or Scientific Coordinator. She serves as a member and secretary of national expert committees and advisory boards and contributes to shaping diagnostic and therapeutic strategies for metabolic disorders in Italy and Europe.

Research Focus

  • Inborn errors of metabolism and rare genetic diseases

  • Lysosomal storage disorders (including LAL-D, Gaucher disease, and alpha-mannosidosis)

  • Phenylketonuria (PKU) and organic acidurias

  • Neonatal screening programs

  • Epidemiology and real-world evidence in pediatric metabolic disorders

  • Nutritional and enzyme replacement therapies in pediatric populations

Author Metrics & Scientific Contributions

  • Principal Investigator in multiple national and international clinical trials

  • Scientific Member of the Telethon Undiagnosed Diseases Program (TUDP) and E-HOD

  • Coordinator/Advisor for over 30 expert boards and working groups, including SIMMESN

  • Co-author of educational and clinical monographs, including:

    • “Inherited Metabolic Disorders Neonatal Screening” (2014)

    • Educational booklets on MSUD, TYR, HCU, MMA/PA, GA, IVA, and PKU (2020–2022)

    • Springer Healthcare Monography (2025) on velmanase alfa treatment in alpha-mannosidosis

She has contributed substantially to national consensus statements, educational masterclasses, and international forums on metabolic disease management.

Publication Top Notes

1. Exploring Partners, Parenting and Pregnancy Thinking in Late Adolescents and Young Adults with Inherited Metabolic Disorders

📅 Pediatric Reports, May 2025
🔗 DOI: 10.3390/pediatric17030056
👩‍🔬 Contributors: Albina Tummolo, Giulia Paterno, Rosa Carella, Livio Melpignano, Donatella De Giovanni
Focus: Examines reproductive health perspectives in adolescents and young adults affected by inherited metabolic disorders.

2. Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?

📅 Pediatric Reports, October 2024
🔗 DOI: 10.3390/pediatric16040076
👩‍🔬 Contributors: Giulia Paterno, Vito Di Tullio, Rosa Carella, Giada De Ruvo, Fabrizio Furioso, Aleksandra Skublewska-D’Elia, Donatella De Giovanni, Albina Tummolo
Focus: Investigates obesity prevalence among patients with phenylketonuria (PKU) versus healthy peers.

3. Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients

📅 Nutrients, February 2024
🔗 DOI: 10.3390/nu16050669
👩‍🔬 Contributors: Albina Tummolo, Rossella Carella, Pasquale Carone, Giulia Paterno, Donatella De Giovanni
Focus: Real-world insights into how PKU patients consume amino acid supplements.

4. CHAMP1-related Disorders: Pathomechanisms Triggered by Different Genomic Alterations Define Distinct Nosological Categories

📅 European Journal of Human Genetics, 2023
🔗 DOI: 10.1038/S41431-023-01305-Z
🔍 WOSUID: WOS:000939855800002
👩‍🔬 Contributors: Amenta S., Marangi G., Orteschi D., Frangella S., Gurrieri F., Paccagnella E., Scala M., Romano F., Capra V., Nigro V., et al.
Focus: Differentiates clinical categories of CHAMP1-related disorders based on genomic mechanisms.

5. Long-term Safety and Efficacy of Velmanase Alfa Treatment in Children Under 6 Years of Age with Alpha-Mannosidosis: A Phase 2, Open Label, Multicenter Study

📅 Journal of Inherited Metabolic Disease, 2023
🔗 DOI: 10.1002/JIMD.12602
🔍 WOSUID: WOS:000948401000001
👩‍🔬 Contributors: Guffon N., Konstantopoulou V., Hennermann J.B., Muschol N., Bruno I., Tummolo A., Ceravolo F., Zardi G., Ballabeni A., Lund A.
Focus: Evaluates velmanase alfa’s therapeutic profile in pediatric alpha-mannosidosis patients.

Conclusion

Dr. Albina Tummolo exemplifies the core values of the Best Researcher Award in Medicine and Health Sciences through her compassion-driven pediatric care, trailblazing research, and influence on national health systems. Her unique blend of clinical depth, academic rigor, and policy impact makes her an ideal candidate for this recognition.

She not only advances medical science but also improves the lives of children with rare diseases—one diagnosis, one protocol, and one family at a time.

Gao Jianhong | Medicine and Health Sciences | Best Researcher Award

Posted on by ScienceFather

Gao Jianhong | Medicine and Health Sciences | Best Researcher Award

Dr Jianhong Gao, upm, Malaysia

Dr. Jianhong Gao is a dedicated sports scientist and research fellow at the National Sports Institute of Malaysia, specializing in injury prevention, rehabilitation, and musculoskeletal health. She holds a bachelor’s degree from First Shandong Medical University, a master’s in sports rehabilitation from Shanghai University of Sport, and a PhD in sports science from Universiti Putra Malaysia. Her expertise lies in developing rehabilitation strategies for elite athletes, focusing on chronic low back pain, biomechanics, and return-to-play protocols. With multiple high-impact publications and funded research projects, she has significantly contributed to the advancement of sports rehabilitation. Dr. Gao collaborates with leading universities and institutions, ensuring evidence-based clinical applications. She is an advocate for innovative rehabilitation techniques like tissue flossing and biomechanical assessment to enhance athletic performance and reduce injury risks. Her research has shaped modern approaches in sports medicine, benefitting both professional athletes and the general population.

Publication Profile

Google Scholar

Education

Dr. Jianhong Gao has a strong academic background in sports science and rehabilitation. She earned her bachelor’s degree in medical sciences from First Shandong Medical University, laying the foundation for her expertise in human physiology and sports medicine. She then pursued a master’s degree in sports rehabilitation from Shanghai University of Sport, where she gained advanced knowledge in musculoskeletal health and injury recovery. Furthering her academic journey, she obtained a PhD in sports science from Universiti Putra Malaysia, focusing on injury prevention and rehabilitation for elite athletes. Her research integrates biomechanics, tissue flossing, and rehabilitation therapy to optimize athletic performance and recovery. Throughout her studies, she engaged in extensive clinical research and collaborated with top experts, shaping her evidence-based approach to sports injury management. Dr. Gao’s academic achievements highlight her commitment to advancing sports science and developing innovative rehabilitation methodologies for athletes worldwide.

Experience

Dr. Jianhong Gao has extensive experience in sports injury prevention and rehabilitation. She is currently a Research Fellow at the National Sports Institute of Malaysia, where she specializes in injury management and performance optimization for elite athletes. She has led multiple funded research projects, including studies on chronic low back pain rehabilitation, biomechanical assessments in martial arts, and injury risk management programs. Her work has contributed to innovative rehabilitation protocols and return-to-play strategies. Dr. Gao actively collaborates with Universiti Malaya, Universiti Putra Malaysia, and Tunku Abdul Rahman University to advance sports science research. She also provides consultation on musculoskeletal disorders for athletes and the general public, integrating biomechanics, myofascial release, and corrective exercises. With a strong academic and clinical background, she continues to bridge the gap between research and practical applications in sports medicine, helping athletes recover efficiently and perform at their peak.

Awards and Honors

Dr. Jianhong Gao’s contributions to sports science and rehabilitation have earned her significant recognition. She has received multiple research grants, including RM100,000 for her study on Flossband rehabilitation for chronic low back pain and RM35,000 for research on karate punching biomechanics. Additionally, she is a key investigator in a RM2.5 million injury risk management project (2024-2027). Her research has been published in prestigious journals indexed in Scopus and SCI, reflecting her expertise in sports injury prevention. Dr. Gao has collaborated with leading universities and sports institutions, further enhancing her impact in the field. Her studies on tissue flossing, biomechanics, and rehabilitation techniques have influenced clinical applications worldwide. As a leading researcher in sports medicine, she has played a crucial role in advancing rehabilitation strategies, making her a deserving candidate for the Best Researcher Award for her outstanding academic and scientific contributions.

Research Focus

Dr. Jianhong Gao’s research revolves around sports injury prevention, chronic low back pain management, and return-to-play strategies. She specializes in biomechanics, myofascial release techniques, and rehabilitation protocols to improve athletic performance and recovery. One of her key research areas is the use of Flossband therapy for musculoskeletal rehabilitation, which she has explored through clinical trials. She has also conducted extensive studies on karate punching biomechanics and strength assessments in elite martial artists. Her work emphasizes evidence-based rehabilitation strategies, integrating tissue flossing, biomechanical analysis, and corrective exercises to minimize injury risks. As an investigator in a multi-million-ringgit injury risk management project, she aims to develop a comprehensive injury prevention framework for professional athletes. Her findings have been instrumental in shaping modern rehabilitation techniques, benefiting not only elite athletes but also individuals suffering from musculoskeletal conditions.

Publication Top Notes

The effect of tissue flossing technique on sports and injury prevention and rehabilitation: a systematic review of recent research

Absolute Reliability and Concurrent Validity of the Modified Goniometric Platform for Measuring Trunk Rotation in the Sitting Position

The potential mechanisms of tissue flossing with Flossband application around the joints or soft tissues: A theoretical framework

Social capital and physical activity: A literature review up to march 2024

Multivariate regression modeling of Chinese artistic gymnastic handspring vaulting kinematic performance based on judges scores

Exploring the role of social capital in enhancing physical activity among college and university students: A systematic review

Comprehensive analysis of college students’ autonomous fitness behavior—a narrative review

 

 

 

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Posted on by ScienceFather

Jonathan Trent | Medicine and Health Sciences | Lifetime achievement Award

Prof. Dr Jonathan Trent, Sylvester Comprehensive Cancer Center, University of Miami, United States

Prof. Dr. Jonathan Trent is a distinguished oncologist and researcher, specializing in sarcoma and precision medicine. With an MD and PhD from The University of Texas Health Science Center, he has dedicated his career to advancing cancer treatment. As Associate Director of Clinical Research at Sylvester Comprehensive Cancer Center, he leads groundbreaking studies in medical oncology. His leadership in precision medicine has transformed sarcoma treatment strategies. A prolific author, he has contributed to numerous high-impact publications, shaping the future of cancer therapy. Recognized for his mentorship and excellence in patient care, he has received prestigious awards like Sylvester Outstanding Mentor of the Year. His commitment to clinical innovation and translational research continues to impact oncology worldwide.

Publication Profile

Scopus

Education

Prof. Dr. Jonathan Trent earned his BS in 1988 from Southeastern Oklahoma State University, Durant, OK. He then pursued an MD-PhD program at The University of Texas Health Science Center, Houston, TX (1988-1995), where he developed expertise in oncology and medical research. His postgraduate training includes a Clinical Internship (1995-1996) and a Clinical Residency (1997-1999) at the same institution. He further specialized in cancer treatment through a Medical Oncology Fellowship at MD Anderson Cancer Center (1999-2002), where he also served as Chief Fellow. His extensive academic training laid a strong foundation for his groundbreaking research in sarcoma and precision medicine.

Experience

Prof. Dr. Jonathan Trent began his academic career as Assistant Professor (2002-2008) and later Associate Professor (2008-2011) at MD Anderson Cancer Center. He also served as an Adjunct Professor (2014-2015) at its Graduate School of Biomedical Sciences. Since 2013, he has been a Professor of Medicine at the University of Miami, where he is also Associate Director of Clinical Research, Director of the Sarcoma Medical Research Program, and Director of Precision Medicine at Sylvester Comprehensive Cancer Center. His leadership in sarcoma research, clinical trials, and precision oncology has significantly advanced cancer treatment.

Awards and Honors

Prof. Dr. Jonathan Trent has received numerous prestigious awards for his contributions to oncology, including the Sylvester Outstanding Mentor of the Year 🏆 (Miller School of Medicine, 2015), the Outstanding Care Award 🏅 (Sarcoma Alliance, 2012), and the Leadership in Clinical Research 🎖️ (Sylvester Comprehensive Cancer Center). He is an esteemed member of elite professional organizations such as the American Society for Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and The Max Foundation. His dedication to oncology research and patient care has earned him national and international recognition.

Research Focus

Prof. Dr. Jonathan Trent’s research focuses on sarcoma, targeted therapies, and precision oncology. He has played a pivotal role in the development of novel therapies, including TRK fusion inhibitors, CDK7-targeted treatments, and IDH1 mutation-based interventions. His work has significantly improved the understanding of leiomyosarcoma, chondrosarcoma, and desmoid tumors. As Director of Sarcoma Medical Research and Precision Medicine at Sylvester Comprehensive Cancer Center, he integrates genomic profiling and personalized treatment strategies to enhance patient outcomes. His extensive clinical trials and translational research have shaped modern sarcoma therapies, contributing to groundbreaking advancements in oncology.

Publication Top Notes

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors

Gastrointestinal Stromal Tumor Patients with Molecular Testing Exhibit Superior Survival Compared to Patients without Testing: Results from the Life Raft Group (LRG) Registry

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours

Use of tyrosine kinase inhibitors in patients with GI stromal tumor who are pregnant or considering pregnancy: Driver mutations and circulating tumor DNA

Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER